Loading...
•
Mar 31, 2021
Stryker Q1 2021 Earnings Report
Stryker's Q1 2021 results showed net sales increased by 10.2% and adjusted EPS increased by 4.9%.
Key Takeaways
Stryker reported a 10.2% increase in net sales and a 4.9% increase in adjusted EPS for the first quarter of 2021. The company is optimistic about continued momentum and the Wright Medical integration.
Reported net sales increased 10.2% from 2020 and 12.4% from 2019 to $4.0 billion.
Organic net sales increased 1.8% from 2020 and 4.7% from 2019.
Reported EPS decreased 39.2% to $0.79.
Adjusted EPS increased 4.9% to $1.93.
Stryker
Stryker
Stryker Revenue by Segment
Revenue by Segment
MedSurg and Neurotechnology Revenue
CapyFin.comOrthopaedics Revenue
CapyFin.com Forward Guidance
Stryker expects 2021 organic net sales growth to be in the range of 8% to 10% from 2019 and adjusted net earnings per diluted share to be in the range of $9.05 to $9.30.
Positive Outlook
- Expect 2021 organic net sales growth to be in the range of 8% to 10% from 2019.
- Expect adjusted net earnings per diluted share to be in the range of $9.05 to $9.30.
- Guidance includes the full year impact of the acquisition of Wright Medical.
- Expect EPS will be positively impacted by $0.05 to $0.10 for the full year if foreign currency exchange rates hold near current levels.
- Guidance assumes an ongoing recovery in key geographies leading to more normalized elective procedure levels during the second quarter of 2021.
Challenges Ahead
- Continue to monitor and evaluate the impact the global response to the COVID-19 pandemic has had, and will continue to have, on our operations and financial results.
- Expect continued unfavorable price reductions of approximately 1% in 2021.
- The impact on our operations and financial results of the COVID-19 pandemic and any related policies and actions by governments or other third parties
- Unexpected liabilities, costs, charges or expenses in connection with the acquisition of Wright Medical Group N.V.
- Weakening of economic conditions that could adversely affect the level of demand for our products
Revenue & Expenses
Visualization of income flow from segment revenue to net income